Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease
Related Experiment Video
Updated: May 2, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Syed Shahid Habib1, Abeer A Al Masri2
1Dr. Syed Shahid Habib, Department of Physiology, College of Medicine & King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Insights
Serum high sensitivity C-reactive protein (hsCRP) is elevated in patients with coronary artery disease (CAD). Higher hsCRP levels correlate with the presence and severity of CAD, indicating its role in atherosclerosis.
Area of Science:
- Cardiology
- Inflammation Research
- Biomarker Discovery
Background:
- Inflammation is a critical factor in atherosclerosis development.
- High sensitivity C-reactive protein (hsCRP) is a key inflammatory marker.
Purpose of the Study:
- To investigate the association between serum hsCRP levels and the presence/severity of coronary artery disease (CAD).
- To evaluate hsCRP as a potential biomarker for CAD.
Main Methods:
- Eighty-seven patients with angiographically confirmed CAD and 29 healthy controls were studied.
- hsCRP and lipid profiles were measured.
- CAD severity was assessed using Gensini and vessel scoring.
Main Results:
- CAD patients exhibited significantly higher hsCRP levels than controls.
- hsCRP showed a significant positive correlation with CAD severity (Gensini score).
- Patients with triple-vessel disease had higher hsCRP than those with one or two-vessel disease.
Conclusions:
- Elevated serum hsCRP levels are associated with angiographically confirmed CAD.
- hsCRP levels correlate with both the presence and severity of CAD.
- hsCRP may serve as a valuable biomarker in evaluating CAD.
Objective:
Inflammation plays a key role in the pathogenesis of atherosclerosis. This study aimed to assess the relationship of serum inflammatory marker high sensitivity C Reactive protein (hsCRP), with the presence and severity of angiographically evaluated coronary artery disease (CAD).
Methods:
This study was conducted at departments of physiology and cardiology, College of Medicine & King Khalid University Hospital, King Saud University, Riyadh from August 2009 to March 2012. Eighty seven patients (57 males and 30 females) with angiographically evaluated CAD were studied. In all these patients CAD severity was assessed by Gensini scoring and vessel scoring. Control group consisted of 29 healthy subjects (17 males and 12 females). Fasting venous blood samples were analyzed for lipid profile and high sensitivity C-reactive protein (hsCRP).
Results:
There were non-significant differences in age, weight and BMI among healthy subjects and CAD patients. Comparison of lipid profile between control and CAD patients showed that CAD patients had significantly higher TG and significantly lower HDL levels compared to control subjects. CAD patients presented with significantly higherhsCRP levels than controls. Linear regression analysis between hsCRP and CAD severity determined by Gensini scores showed a significant positive correlation (r=0.423, p=0.018). Triple vessel disease patients had significantly higher hsCRP levels than one vessel and two vessel disease, while the difference was non significant between one and two vessel disease groups.
Conclusions:
These results suggest that patients with angiographically evaluated CAD have significantly higher levels of hsCRP levels compared to healthy individuals and are correlated with the presence & severity of CAD.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

